North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 6 of 6
Details
LDL
Link Added : MHRA Drug Safety Update (June 2017): Brimonidine gel (Mirvaso): risk of systemic cardiovascular effects; not to be applied to damaged skin : https://www.gov.uk/drug-safety-update/brimonidine-gel-mirvaso-risk-of-systemic-cardiovascular-effects
11/07/2023 14:07:45
(ebeavers )
LDL
Link Added : MHRA Drug Safety Update (Nov 2016): Brimonidine gel (Mirvaso): risk of exacerbation of rosacea : https://www.gov.uk/drug-safety-update/brimonidine-gel-mirvaso-risk-of-exacerbation-of-rosacea
11/07/2023 14:07:00
(ebeavers )
UPD
Brimonidine Tartate 0.33% gel (Mirvaso
®
) b
30/01/2017 11:42:05
(WhitehallJ )
UPD
Brimonidine Tartate 0.33% gel (Mirvaso
®
) b
19/01/2017 08:26:04
(DavidS )
UPD
Brimonidine 0.33% gel (Mirvaso
®
) b
19/01/2017 08:25:53
(DavidS )
UPD
Brimonidine gel (Mirvaso
®
) build
20/12/2016 11:12:01
(DavidS )
